In another meta-analysis to understand the effects of Astragalus membranaceus in diabetic nephropathy, it was concluded that in comparison to the control group, astragalus injection had a greater therapeutic impact on DN patients, improving systemic condition (serum albumin level), renal protective effect (BUN, SCr, CCr, and urine protein) [128]. This evidence concerns the gene ALB and diabetic kidney disease.